-
1
المصدر: EXPERT OPINION ON PHARMACOTHERAPY. 15(18):2629-2639
مصطلحات موضوعية: locoregional recurrence, in-transit melanoma, IN-TRANSIT MELANOMA, TOPICAL DIPHENCYPRONE IMMUNOTHERAPY, GM-CSF, intralesional, MALIGNANT-MELANOMA, DNA-LIPOSOME COMPLEXES, AZELAIC ACID, melanoma, ROSE-BENGAL, BACILLE CALMETTE-GUERIN, DIRECT GENE-TRANSFER, PHASE-II TRIAL
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dris___01423::f31a4edcff2254d554f761197d06ce59Test
https://research.rug.nl/en/publications/d9384eb5-f5b3-4572-9663-77db739c28bbTest -
2
المؤلفون: Sarah Sloot, Jonathan S. Zager, Omar M. Rashid
المصدر: Expert Opinion on Pharmacotherapy. 15:2629-2639
مصطلحات موضوعية: Oncology, locoregional recurrence, medicine.medical_specialty, Pathology, Skin Neoplasms, Metastatic melanoma, Administration, Topical, Electrochemotherapy, Antineoplastic Agents, Systemic immunity, Systemic therapy, MALIGNANT-MELANOMA, In vivo, Internal medicine, melanoma, medicine, Bystander effect, Humans, BACILLE CALMETTE-GUERIN, Pharmacology (medical), Advanced melanoma, Pharmacology, Clinical Trials as Topic, Infusions, Intralesional, in-transit melanoma, business.industry, Melanoma, TOPICAL DIPHENCYPRONE IMMUNOTHERAPY, Drug administration, GM-CSF, General Medicine, intralesional, medicine.disease, DNA-LIPOSOME COMPLEXES, AZELAIC ACID, ROSE-BENGAL, DIRECT GENE-TRANSFER, business, PHASE-II TRIAL, Immunosuppressive Agents
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845cabf56d21b50ada3307b825e6ef26Test
https://doi.org/10.1517/14656566.2014.967682Test